Telix Pharmaceuticals (TLX) Q3 2025 Earnings

20AugConfirmed
Q3 2024
Q1 2025
Q3 2025
-0.01
0.04
0.09
0.13

Details

Expected EPS
0.133374
Actual EPS
-0.0068
Surprise EPS
-0.14
Surprise Percent
+105.1%

Description

Telix Pharmaceuticals (TLX) has reported earnings of -0.0068 per share for Q3 2025.

0 Comments

Share your thoughts